• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER TALISMAN PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER TALISMAN PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number 9-PFO-1818
Medical Device Problem Code Migration or Expulsion of Device (1395)
Health Effect - Clinical Code Obstruction/Occlusion (2422)
Date of Event 06/05/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that on (b)(6) 2024, a 18-18mm amplatzer talisman pfo occluder was chosen for implant using a unknown delivery system.During procedure, there was some difficulty due to the patient being small and their septum was very floppy.The device was positioned in patent foramen ovale and transthoracic echocardiogram (tte) was used to evaluate the position of the device.The device was released, but the patient needed more procedures completed.While completing the other procedures the device location had changed and upon review it was seen in left ventricle.There was partial obstruction/blockage of blood flow.Due to patient size, transvenous retrieval procedure was not an option and the device was surgically retrieved.The cause of embolization was unknown.The patient was reported stable.
 
Additional Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Additional Manufacturer Narrative
An event of migration or expulsion of device and partial obstruction/blockage of blood flow was reported.A returned device assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Based on the information received, the cause for the reported migration or expulsion of device (device embolization) could not be determined.There is no indication of a product quality issue with respect to labeling, design, or manufacturing of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER TALISMAN PFO OCCLUDER
Common Device Name
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key19615471
Report Number2135147-2024-03028
Device Sequence Number6140704
Product Code MLV
UDI-Device Identifier05415067033307
UDI-Public(01)05415067033307(17)241031(10)8221784
Combination Product (Y/N)N
Initial Reporter StateIA
Initial Reporter CountryUS
PMA/510(K) Number
P120021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2024
Device Catalogue Number9-PFO-1818
Device Lot Number8221784
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 06/05/2024
Supplement Date Received by Manufacturer07/05/2024
Initial Report FDA Received Date06/26/2024
Supplement Report FDA Received Date07/17/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/15/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening; Required Intervention;
Patient Age13 MO
Patient SexUnknown
-
-